Usher Institute, Medical School, University of Edinburgh, Edinburgh, United Kingdom.
Wellcome Trust-Medical Research Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom.
Diabetes Technol Ther. 2020 Jun;22(6):468-475. doi: 10.1089/dia.2019.0466. Epub 2020 Mar 6.
We explored health professionals' views about the training, support, and resourcing needed to support people using closed-loop technology in routine clinical care to help inform the development of formal guidance. Interviews were conducted with health professionals ( = 22) delivering the Closed Loop from Onset in Type 1 Diabetes (CLOuD) trial after they had ≥6 months' experience of supporting participants using a closed-loop system. Data were analyzed descriptively. Interviewees described how, compared with other insulin regimens, teaching and supporting individuals to use a closed-loop system could be initially more time-consuming. However, they also noted that after an initial adjustment period, users had less need for initiating contact with the clinical team compared with people using pumps or multiple daily injections. Interviewees highlighted how a lessened need for ad hoc clinical input could result in new challenges; specifically, they had fewer opportunities to reinforce users' diabetes knowledge and skills and detect potential psychosocial problems. They also observed heightened anxiety among some parents due to the constant availability of data and unrealistic expectations about the system's capabilities. Interviewees noted that all local diabetes teams should be empowered to deliver closed-loop system care, but stressed that health professionals supporting closed-loop users in routine care will need comprehensive technology training and standardized clinical guidance. These findings constitute an important starting point for the development of formal guidance to support the rollout of closed-loop technology. Our recommendations, if actioned, will help limit the potential additional burden of introducing closed-loop systems in routine clinical care and help inform appropriate user education and support.
我们探讨了卫生专业人员对培训、支持和资源的看法,这些都是支持在常规临床护理中使用闭环技术的人员所必需的,以帮助制定正式指南。在有≥6 个月支持使用闭环系统的参与者的经验后,对正在实施 1 型糖尿病闭环起始试验(CLOuD)的卫生专业人员( = 22)进行了访谈。对数据进行了描述性分析。受访者描述了与其他胰岛素方案相比,教授和支持个人使用闭环系统可能最初会更加耗时。然而,他们还指出,在初始调整期之后,与使用泵或多次每日注射的人相比,用户与临床团队联系的需求减少。受访者强调,由于不需要临时的临床投入,可能会带来新的挑战;具体来说,他们强化用户糖尿病知识和技能以及发现潜在心理社会问题的机会减少了。他们还观察到,由于数据的持续可用性和对系统功能的不切实际期望,一些家长感到更加焦虑。受访者指出,所有当地的糖尿病团队都应该有能力提供闭环系统护理,但强调支持常规护理中闭环用户的卫生专业人员将需要全面的技术培训和标准化的临床指导。这些发现为制定正式指南以支持闭环技术的推出提供了重要的起点。如果采取我们的建议,将有助于限制在常规临床护理中引入闭环系统的潜在额外负担,并有助于为适当的用户教育和支持提供信息。